Psilocybin Alcohol Use Disorder: What Hopkins and NYU Research Found
Research on psilocybin alcohol use disorder treatment, including a landmark 2022 randomized controlled trial published in JAMA Psychiatry, has shown meaningful reductions in heavy drinking days...
Psilocybin PTSD Therapy: What the 2026 Clinical Evidence Shows
Psilocybin PTSD therapy is no longer a fringe concept. A growing body of clinical research, including Phase 2 trials published in 2025, shows that a single...
Psychedelics for Depression: What the 2026 Research Actually Shows
Quick Answer Psilocybin and other psychedelics show real, measurable promise for depression, particularly treatment-resistant cases. But the evidence in 2026 is more complicated, more honest, and...
MDMA Therapy FDA Decision, What the Rejection Letter Means for Seekers
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time,...
Can Psilocybin Slow Aging? A New Study Hints at What’s Possible
A peer-reviewed study in npj Aging found that psilocybin and aging may be more connected than previously assumed, after treated female mice showed reduced oxidative stress,...
Ketamine Therapy Preparation: What to Expect and Why It Matters
Ketamine therapy preparation is not a formality you complete before the real thing begins. It is a functional part of what makes the treatment work. What...
AI Digital Tripsitter: What It Can and Cannot Do for You
An AI digital tripsitter is a software tool, usually an app or chatbot, designed to support psychedelic experiences through journaling prompts, intention-setting, and guided reflection. These...
Healing Together: Psychedelic Therapy, Partnership, and the Power of Personalized Guidance
Psychedelic guide matching is one of the most important decisions a seeker can make, and at JourneyŌM, it is never left to an algorithm. This post...
Psychedelic Nasal Spray for Depression: What the Research Shows
A psychedelic nasal spray for depression called BPL-003 has produced rapid, meaningful antidepressant effects in clinical trials, earning FDA Breakthrough Therapy designation in late 2025. The...
Psychedelic Therapy for Veterans: What the Research Shows
Psychedelic therapy for veterans is one of the most actively researched areas in mental health today. Clinical trials involving MDMA and psilocybin have shown meaningful reductions...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.